Ameriprise’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.43M Buy
2024
Q2
Sell
2024
Q1
$78.1K Sell
2023
Q4
$68K Sell
2023
Q3
$531K Buy
2023
Q2
$791K Buy
2023
Q1
$581K Sell
2022
Q4
$1.14M Sell
2022
Q3
$1.15M Sell
2022
Q2
$1.05M Sell
2022
Q1
$1.31M Buy
2021
Q4
$1.08M Buy
2017
Q2
Sell
2017
Q1
$1.34M Sell
2016
Q4
$1.31M Buy